Federated Hermes, Inc. Codex Dna, Inc. Transaction History

Federated Hermes, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.31 - $11.96 $63,099 - $119,600	-10,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$10.15 - $19.88 $355,250 - $695,800	-35,000 Reduced 77.78%	10,000 $111,000
Q2 2021 Aug 16, 2021	BUY	$17.76 - $22.0 $799,200 - $990,000	45,000 New	45,000 $990,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.